Video Latest - ecancer

Predictors of response to mCRPC therapy: where do we stand?

Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands

10 Jan 2014

Managing mCRPC in daily practice: a pragmatic approach

Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK

10 Jan 2014

Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion

J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle

10 Jan 2014

The Personalized Medicine project: Biobanking solutions

Dr Gabriele Weiler - Fraunhofer IBMT, Germany

6 Jan 2014

The Personalized Medicine project: Developing the clinical trial management tool

Prof Norbert Graf - Saarland University, Germany

6 Jan 2014

The Personalized Medicine project: The ObTiMA tool

Dr Simona Rossi - Swiss Institute of Bioinformatics, Switzerland

6 Jan 2014

The Personalized Medicine project: The ALGA Questionnaire

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

6 Jan 2014

The Personalized Medicine project: Developing software for clinical trials

Holger Stenzhorn - Saarland University Hospital, Germany

6 Jan 2014

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA

1 Jan 2014

Rituximab maintenance therapy and CLL treatment considerations going forward

Prof Ulrich Jäger - Medical University of Vienna, Austria

1 Jan 2014

Symptom management and quality of life in metastatic breast cancer

Dr Polly Niravath - Baylor College of Medicine, Houston, Texas

20 Dec 2013

The impact of biological age on breast cancer

Dr Alistair Ring - Brighton and Sussex Medical School, UK

20 Dec 2013

Video